ST JUDE MEDICAL INC SAN DIEGO, Aug. 7, 2014 /PRNewswire/ -- Volcano Corporation (Nasdaq: VOLC), a leading company focused on improving patient and economic outcomes on a global basis by developing and delivering innovative minimally invasive coronary and peripheral visualization, physiology diagnostics and therapies, today reported results for the second quarter and first six months of 2014.
The company also announced today that it will be seeking a divestiture of its Axsun Technologies, Inc. subsidiary. In addition, the company said that it and St. Jude Medical, Inc., (NYSE: STJ) have agreed to settle all existing litigation between the two companies.
For the quarter ended June 30, 2014, Volcano reported revenues of $102.6 million versus revenues of $101.3 million in the same period a year ago. Foreign currency exchange rates did not have a material impact on revenues during the quarter. Medical segment revenues increased approximately two percent on a reported basis.
The company reported net income on a GAAP basis of $282,000, or $0.01 per diluted share, in the second quarter of 2014, versus a net loss of $2.4 million, or $0.04 per share, in the same period a year ago. The results for the second quarter of 2014 included an acquisition-related benefit of $7.2 million related to an adjustment to a contingent liability resulting in a net benefit of $6.4 million, while the results for the second quarter of 2013 included a gain on a strategic investment of $2.2 million. Excluding acquisition-related items, amortization of intangibles and non-cash interest expense on convertible notes, net of tax, the company reported non-GAAP net income of $0.01 per diluted share, compared with non-GAAP earnings per diluted share of $0.03 in the second quarter a year ago.
For the first six months of 2014, Volcano reported revenues of $197.1 million versus revenues of $194.6 million in the first six months of 2013. On a constant currency basis, revenues increased three percent year-over-year after adjusting for a negative impact of approximately $2.7 million from foreign currency. Medical segment revenues increased approximately two and three percent on a reported and constant currency basis, respectively, versus the first six months of 2013.
For the first six months of 2014, the company reported a net loss on a GAAP basis of $10.6 million, or $0.21 per share, versus a net loss of $5.5 million, or $0.10 per share, in the same period a year ago. The results for the first six months of 2014 included a net acquisition-related benefit of $5.4 million, while the results for the first six months of 2013 included other income of $4.2 million. Excluding acquisition-related items, amortization of intangibles and non-cash interest expense on convertible notes, net of tax, the company reported a non-GAAP net loss of $0.10 per share in the first six months of 2014, compared with non-GAAP net earnings per diluted share of $0.06 in the first six months of 2013.
"Our results for the quarter reflect continued expansion of our IVUS (Intravascular Ultrasound) peripheral business in the U.S. and strong growth for our FFR (Fractional Flow Reserve) disposable business in Japan and Europe," said Scott Huennekens, president and chief executive officer. "These gains helped offset the impact of the continued decline in our coronary IVUS disposable activity."
"The second quarter was highlighted by the acquisition of AtheroMed, Inc., and its Phoenix® Atherectomy System used in the treatment of peripheral artery disease," he continued. "We are on track to initiate a limited market release of the Phoenix device later this year and a full market release in early 2015. In addition, during the quarter we began the roll out of our iFR® (Instant Wave-Free Ratio(TM)) FFR offering and SyncVision(TM) Co- Registration System in the U.S.," he added.
With respect to the planned Axsun divestiture, Huennekens said, "This decision was driven by our long-term strategy to focus on coronary imaging and physiology leadership, peripheral expansion, profitability and business scale. The Axsun business and financial model is no longer a strategic fit with Volcano. We greatly appreciate the significant contributions of the Axsun team to Volcano over the past several years."
Under terms of the settlement with St. Jude Medical, the parties have agreed to dismiss their lawsuits with prejudice, with neither party admitting liability to the other. Each party will be granted a release of liability for alleged misconduct, granted a license to all patents-in-suite and granted a covenant not to sue as to various current and future products. As part of the settlement agreement, no financial payments will be made to either party by the other.
"We are pleased with the resolution of these litigation matters and believe this settlement will enable us to better focus on the needs of doctors and patients," Huennekens said.
Guidance
The company provided updated guidance for the full year 2014. Based on current foreign currency exchange rates, it expects revenues on a reported basis will be $397.0-$401.0 million, with revenues on a constant currency basis in the range of $401.0-$405.0 million. The company said it expects gross margins will be in the range of 63.0-63.5 percent and that operating expenses, including restructuring charges, will be 65.5-66.5 percent of revenues. On a reported basis, the company expects a GAAP net loss of $0.52-$0.55 per share. The company is maintaining its prior guidance for a net loss per share of $0.16-$0.19 on a non-GAAP basis. The company said it has been able to offset its revised outlook for revenues with expense reprioritization initiatives related to SG&A and R&D expenses, resulting in expected lower operating expenses as a percentage of revenues. Non-GAAP results exclude acquisition-related expenses, amortization of intangibles and non-cash interest expense, and assume an effective tax rate of 35.0 percent for the GAAP to non-GAAP adjustments. The company expects weighted average basic shares in 2014 will be approximately 51.4 million.
For the third quarter of 2014, Volcano expects revenues in the range of $95.0-$97.0 million on a reported and $95.5-$97.5 million constant currency basis. It expects gross margins will be in the range of 62.0-62.5 percent and that operating expenses will be in the range of 69.0-70.0 percent of revenues. The company expects a net loss per share of $0.17-$0.19 on a GAAP basis and $0.04-$0.06 on a non-GAAP basis.
Conference Call Information
The company will hold a conference call at 2 p.m., Pacific Daylight Time, (5 p.m., Eastern Daylight Time) today. The teleconference can be accessed by calling (631) 291-4555, passcode 66540992, or via the company's website at http://www.volcanocorp.com. Please dial in or access the webcast 10-15 minutes prior to the beginning of the call. A replay of the conference call will be available through August 10, at (404) 537-3406, passcode 66540992, and via the company's website at http://www.volcanocorp.com.
About Volcano Corporation
Through its multi-modality platform, Volcano Corporation is the global leader in intravascular imaging for coronary and peripheral applications, and physiology. The company also offers a suite of peripheral therapeutic devices. The company's broad range of technologies makes imaging and therapy simpler, more informative and less invasive and offers physicians and their patients around the world with industry-leading tools that aid diagnosis and guide and provide therapy. Founded in cardiovascular care and expanding into other specialties, Volcano is focused on improving patient and economic outcomes. For more information, visit the company's website at www.volcanocorp.com.
Note Regarding the Use of Non-GAAP Financial Measures
The presentation of non-GAAP financial information is not intended to be considered in isolation or as a substitute for, or superior to, the financial information prepared and presented in accordance with GAAP. The company uses non-GAAP financial measures for financial and operational decision making as a measure to compare period-to-period results. The company believes that they provide useful information about operating results, enhance the overall understanding of operating results and future prospects, and allow for greater transparency with respect to key metrics used by management in its financial and operational decision making.
Constant Currency Basis Revenue Changes: Volcano reports changes on a constant currency basis, which is a non-GAAP financial measure. Volcano believes that investors' understanding of the company's short-term and long-term financial results is enhanced by taking into consideration the impact of foreign currency translation on revenues. In addition, Volcano's management uses results of operations before currency translation to evaluate the operational performance of Volcano and as a basis for strategic planning.
Volcano reports its expectations of earnings per share performance excluding certain expenses described below; for additional details please see the "Reconciliation of GAAP to non-GAAP EPS Guidance," table in this press release. This accompanying table has more details on the GAAP financial measures that are most directly comparable to non-GAAP financial measures and the related reconciliations between these financial measures.
Exclusion of Acquisition-Related Expenses: Volcano excludes acquisition-related expenses because it does not consider these acquisition-related costs and adjustments to be related to the continuing organic operations of the acquired businesses and are generally not relevant to assessing or estimating the long-term performance of the acquired assets. In addition, the size, complexity and/or volume of past acquisitions, which often drive the magnitude of acquisition-related costs, may not be indicative of the size, complexity and/or volume of future acquisitions.
Exclusion of Amortization of Intangibles: Volcano excludes amortization of intangibles because it is a non-cash expense relating primarily to acquisitions. At the time of an acquisition, the intangible assets of the acquired company, which consist primarily of developed or in-process technology, are valued and amortized over their estimated lives. Volcano believes that since intangible assets represent efforts of the acquired company to build value prior to the acquisition, Volcano management eliminates the impact of the amortization when evaluating its current operating performance.
Exclusion of Non-Cash Interest Expenses: In addition to disclosing the financial statement impact of the authoritative guidance for convertible debt accounting, Volcano management believes that excluding the impact of this authoritative guidance is appropriate because it is non-cash in nature, may provide meaningful supplemental information regarding elements of the company's borrowing costs in order to properly understand its operational performance and liquidity, and facilitates comparisons to competitors' results.
Forward-Looking Statements
This press release contains forward-looking statements within the meaning of the U.S. Private Securities Litigation Reform Act of 1995. Any statements in this press release regarding Volcano's business that are not historical facts may be considered "forward-looking statements," including statements regarding Volcano's expected revenues, revenue growth, margins, financial results and foreign currency exchange rates for the third and fourth quarter and calendar year 2014, its growth and other strategies and ability to execute on these strategies, the potential Axsun divestiture, competitive position, target markets, development of its base business and pipeline, product launches, benefits from recent acquisitions and benefits from its products and technologies, including new products. Forward-looking statements are based on management's current expectations and are subject to risks and uncertainties that may cause Volcano's actual results to differ materially and adversely from statements contained herein. Some of the potential risks and uncertainties that could cause actual results to differ include the risks that Volcano's revenues or other projections may turn out to be inaccurate or Volcano may encounter unanticipated difficulty in achieving these projections; global and regional macroeconomic conditions, generally, and in the medical device and telecom industries, specifically; currency exchange rate fluctuations; the effect of competitive factors and the company's reactions to those factors; purchasing decisions with respect to the company's products; the pace and extent of market adoption of the company's products and technologies; uncertainty in the process of obtaining regulatory approval or clearances for Volcano's products or devices; the success of Volcano's growth and other strategies, including the integration of recently-acquired businesses and our ability to integrate businesses from potential future acquisitions; risks associated with Volcano's international operations; the ability to divest Axsun, if at all, and in a timely or beneficial manner; timing and achievement of product development milestones; outcome of ongoing and future litigation, investigations or claims; the impact and benefits of market development and the related size of Volcano's addressable markets; our ability to protect our intellectual property; dependence upon third parties; unexpected new data, safety and technical issues; market conditions and other risks inherent to medical and/or telecom device development and commercialization. These and additional risks and uncertainties are fully described in Volcano's filings made with the Securities and Exchange Commission, including our 10-Q for the quarter ended March 31, 2014, which should be read in conjunction with these financial results. Undue reliance should not be placed on forward-looking statements, which speak only as of the date they are made. Volcano disclaims any obligation to update any forward-looking statements to reflect new information, events or circumstances after the date they are made, or to reflect the occurrence of unanticipated events.
VOLCANO CORPORATION
CONDENSED CONSOLIDATED BALANCE SHEETS
(in thousands)
(unaudited)
June 30, December 31,
2014 2013
---- ----
Assets
Current assets:
Cash and
cash
equivalents $56,182 $107,159
Short-
term
available-
for-sale
investments 149,981 230,775
Accounts
receivable,
net 85,097 81,962
Inventories 72,170 60,970
Prepaid
expenses
and other
current
assets 24,960 28,525
Total
current
assets 388,390 509,391
Long-term
available-
for-sale
investments 35,510 34,750
Property
and
equipment,
net 122,471 118,094
Intangible
assets,
net 126,970 58,108
Goodwill 150,882 55,087
Other non-
current
assets 56,330 56,489
Total
Assets $880,553 $831,919
======== ========
Liabilities and Stockholders'
Equity
Current liabilities:
Accounts
payable $13,207 $19,137
Accrued
compensation 28,277 26,918
Accrued
expenses
and other
current
liabilities 29,979 28,453
Deferred
revenues 11,119 10,652
Contingent
consideration 14,450 3,750
Total
current
liabilities 97,032 88,910
Convertible
senior
notes 410,868 401,012
Other
long-
term debt 1,208 1,268
Deferred
revenues 4,802 5,079
Contingent
consideration,
non-
current
portion 52,984 29,888
Other non-
current
liabilities 6,523 5,960
Total
liabilities 573,417 532,117
Stockholders'
equity 307,136 299,802
------- -------
Total
Liabilities
and
Stockholders'
Equity $880,553 $831,919
======== ========
VOLCANO CORPORATION
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(in thousands, except per share data)
(unaudited)
Three Months Ended Six Months Ended
June 30, June 30,
-------- --------
2014 2013 2014 2013
---- ---- ---- ----
Revenues $102,605 $101,344 $197,133 $194,575
Cost of revenues, excluding amortization
of intangibles 37,711 36,039 72,794 69,166
------ ------ ------ ------
Gross profit 64,894 65,305 124,339 125,409
Operating expenses:
Selling, general and administrative 49,353 45,734 99,664 89,563
Research and development 13,700 17,954 27,657 33,605
Amortization of intangibles 1,818 820 3,601 1,654
Acquisition related items (6,441) 911 (5,405) 2,489
Restructuring items (841) - 32 -
Total operating expenses 57,589 65,419 125,549 127,311
------ ------ ------- -------
Operating income (loss) 7,305 (114) (1,210) (1,902)
Interest income 281 305 596 643
Interest expense (7,320) (6,607) (14,498) (13,152)
Exchange rate (loss) gain (13) (301) 71 (1,079)
Other, net 14 2,279 124 4,177
--- ----- --- -----
Income (loss) before income tax 267 (4,438) (14,917) (11,313)
Income tax benefit (15) (2,050) (4,295) (5,764)
--- ------ ------ ------
Net income (loss) $282 $(2,388) $(10,622) $(5,549)
==== ======= ======== =======
Net income (loss) per share:
Basic $0.01 $(0.04) $(0.21) $(0.10)
===== ====== ====== ======
Diluted $0.01 $(0.04) $(0.21) $(0.10)
===== ====== ====== ======
Shares used in calculating net income
(loss) per share:
Basic 51,300 54,574 51,630 54,389
====== ====== ====== ======
Diluted 51,674 54,574 51,630 54,389
====== ====== ====== ======
VOLCANO CORPORATION
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(in thousands)
(unaudited)
Six Months Ended
June 30,
--------
2014 2013
---- ----
Operating activities
Net loss $(10,622) $(5,549)
Adjustments to
reconcile net loss
to net cash used in
operating activities:
Depreciation and
amortization 15,212 12,223
Amortization of
investment premium,
net 1,866 1,378
Accretion of debt
discount on
convertible senior
notes and other long-
term debt 9,881 9,341
Changes in contingent
consideration (6,204) 1,656
Non-cash stock
compensation expense 7,515 7,847
Asset impairment
related to
restructuring 818 -
Gain on sale of other
long-term investment (365) (1,925)
Effect of exchange
rate changes and
others (953) 9,139
Deferred income taxes 1,014 -
Changes in operating
assets and
liabilities, net of
acquisitions (20,103) (32,583)
------- -------
Net cash (used in)
provided by operating
activities (1,941) 1,527
------ -----
Investing activities
Purchase of short-
term and long-term
available-for-sale
securities (120,514) (154,887)
Sale or maturity of
short-term and long-
term available-for-
sale securities 198,621 139,494
Capital expenditures (14,661) (18,490)
Cash paid for
intangible assets and
other investments (4,941) (1,692)
Proceeds from sale of
other long-term
investments 365 3,426
Cash paid for
acquisitions, net of
cash acquired (114,791) -
-------- ---
Net cash used in
investing activities (55,921) (32,149)
------- -------
Financing activities
Repayment of capital
lease liability (19) (15)
Cash paid to settle
contingent liability
related to
acquisition (2,900) -
Proceeds from sale of
common stock under
employee stock
purchase plan 1,851 1,713
Proceeds from exercise
of common stock
options 7,691 1,185
Net cash provided by
financing activities 6,623 2,883
Effect of exchange
rate changes on cash
and cash equivalents 262 (1,136)
--- ------
Net decrease in cash
and cash equivalents (50,977) (28,875)
Cash and cash
equivalents,
beginning of period 107,159 330,635
------- -------
Cash and
cash
equivalents,
end of
period $56,182 $301,760
======= ========
VOLCANO CORPORATION
REVENUE SUMMARY
(in millions)
(unaudited)
Three Months Ended Percentage Currency Impact Constant
Change Currency
Percentage
Change
June 30,
--------
2014 2013 2013 to 2014 Dollar Percentage
---- ---- ------------ ------ ----------
Medical segment:
Consoles:
United States $5.7 $6.9 (18)% $ - - % (18)%
Japan 0.2 0.1 16 - (4) 20
Europe 3.1 2.7 17 0.2 6 11
Rest of world 1.2 1.8 (35) - - (35)
Total Consoles $10.2 $11.5 (12) $0.2 1 (13)
IVUS single-procedure disposables:
United States $22.7 $20.7 10% $ - - % 10%
Japan 15.8 20.6 (23) (0.9) (4) (19)
Europe 6.9 6.4 9 0.4 6 3
Rest of world 2.9 2.2 33 - - 33
Total IVUS single-
procedure
disposables $48.3 $49.9 (3) $(0.5) (1) (2)
FFR single-procedure disposables:
United States $15.2 $15.1 2% $ - - % 2%
Japan 5.5 4.4 23 (0.3) (6) 29
Europe 10.6 8.0 32 0.6 7 25
Rest of world 0.8 1.2 (33) - - (33)
Total FFR single-
procedure
disposables $32.1 $28.7 12 $0.3 1 11
Other $10.2 $8.9 13% $(0.1) (1)% 14%
Sub-total medical
segment $100.7 $99.0 2 $(0.1) - 2
Industrial segment $1.9 $2.3 (19) $ - - (19)
Total $102.6 $101.3 1 $(0.1) - 1
====== ====== =====
VOLCANO CORPORATION
REVENUE SUMMARY
(in millions)
(unaudited)
Six Months Ended Percentage Currency Impact Constant
Change Currency
Percentage
Change
June 30,
--------
2014 2013 2013 to 2014 Dollar Percentage
---- ---- ------------ ------ ----------
Medical segment:
Consoles:
United States $9.3 $11.7 (21)% $ - - % (21)%
Japan 1.2 1.1 4 (0.1) (11) 15
Europe 5.5 4.2 30 0.3 6 24
Rest of world 2.7 3.5 (23) - - (23)
Total Consoles $18.7 $20.5 (9) $0.2 1 (10)
IVUS single-procedure disposables:
United States $43.7 $40.0 10% $ - - % 10%
Japan 32.2 41.3 (22) (3.2) (8) (14)
Europe 13.5 12.2 11 0.6 5 6
Rest of world 5.6 4.4 27 - - 27
Total IVUS single-
procedure
disposables $95.0 $97.8 (3) $(2.6) (3) -
FFR single-procedure disposables:
United States $28.9 $28.7 1% $ - - % 1%
Japan 9.9 8.9 12 (0.9) (10) 22
Europe 20.0 15.9 26 0.9 5 21
Rest of world 2.0 2.0 - - - -
Total FFR single-
procedure
disposables $60.9 $55.5 10 $ - - 10
Other $19.2 $16.9 13% $(0.3) (2)% 15%
Sub-total medical
segment $193.7 $190.7 2 $(2.7) (1) 3
Industrial segment $3.4 $3.8 (12) $ - - (12)
Total $197.1 $194.6 1 $(2.7) (2) 3
====== ====== =====
VOLCANO CORPORATION
RECONCILIATION OF GAAP RESULTS TO NON-GAAP RESULTS
(in thousands, except per share data)
(Unaudited)
Three Months Ended
June 30, 2014 Pre-tax Adjustments Net of Tax (1) Earnings / (Loss) Per Share
------------------ ------------------- ------------- ---------------------------
GAAP net income $282 $0.01
Acquisition related
items (6,441) (4,187) (0.08)
Amortization of
intangibles 1,818 1,182 0.02
Non-cash interest
expense on
convertible notes 5,011 3,257 0.06
Non-GAAP net
income $388 $534 $0.01
==== ==== =====
Weighted average shares outstanding-diluted 51,674
======
Six Months Ended
June 30, 2014 Pre-tax Adjustments Net of Tax (1) Earnings / (Loss) Per Share
---------------- ------------------- ------------- ---------------------------
GAAP net loss $(10,622) $(0.21)
Acquisition related
items (5,405) (3,513) (0.07)
Amortization of
intangibles 3,601 2,341 0.05
Non-cash interest
expense on
convertible notes 9,935 6,458 0.13
Non-GAAP net loss $8,131 $(5,336) $(0.10)
====== ======= ======
Weighted average shares outstanding-basic 51,630
======
(1) Effective tax rate of 35% applied to non-GAAP adjustments
VOLCANO CORPORATION
RECONCILIATION OF GAAP TO NON-GAAP GUIDANCE
(in thousands, except per share data)
(Unaudited)
Q3 2014
-------
Guidance Range
--------------
From To
---- ---
GAAP net loss per
share-basic $(0.17) $(0.19)
Acquisition related
items 0.03 0.03
Amortization of
intangibles 0.04 0.04
Non-cash interest
expense 0.06 0.06
Non-GAAP net loss
per share-basic $(0.04) $(0.06)
====== ======
Weighted average
shares outstanding-
basic 51,415 51,415
====== ======
2014
----
Guidance Range
--------------
From To
---- ---
GAAP net loss per
share-basic $(0.52) $(0.55)
Acquisition related
items (0.02) (0.02)
Amortization of
intangibles 0.12 0.12
Non-cash interest
expense 0.26 0.26
Non-GAAP net loss
per share-basic $(0.16) $(0.19)
====== ======
Weighted average
shares outstanding-
basic 51,440 51,440
====== ======
Note: Effective tax rate of 35% applied to non-GAAP
adjustments
SOURCE Volcano Corporation
